When and how to include vulnerable subjects in clinical trials

There has been a good deal of discussion in the literature regarding which subjects are vulnerable in the context of clinical trials. There has been significantly less discussion regarding when and how to include vulnerable subjects in clinical trials. This lack of guidance is a particular problem f...

Full description

Saved in:
Bibliographic Details
Published inClinical trials (London, England) Vol. 17; no. 6; p. 696
Main Author Wendler, David
Format Journal Article
LanguageEnglish
Published England 01.12.2020
Subjects
Online AccessGet more information

Cover

Loading…